The protective effects of curcumin on experimental acute liver lesion induced by intestinal ischemia-reperfusion through inhibiting the pathway of NF-κB in a rat model

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Fan, Zhe ^a   Jing, Huirong ^b   Yao, Jihong ^b   Li, Yang ^c   Hu, Xiaowei ^b   Shao, Huizhu ^b   Shen, Gang ^d   Pan, Jiyong ^a   Luo, Fuwen ^b   Tian, Xiaofeng ^b  

^a Department of Medical Services   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

^d Dalian Children's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION; TISSUE;

ANTI-INFLAMMATORY EFFECTS; ANTIOXIDATIVE; CELL ADHESION MOLECULES; FEMORAL VEIN; INTESTINAL ISCHEMIA; LIVER LESIONS; NUCLEAR FACTOR KAPPAB; PROTECTIVE EFFECTS;

RATS;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PEROXIDASE; PROTECTIVE AGENT; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; ENZYME INHIBITION; FEMORAL VEIN; HISTOPATHOLOGY; INTESTINE ISCHEMIA; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; RAT; REPERFUSION INJURY; SEROLOGY; SHAM PROCEDURE; ACUTE DISEASE; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; LIVER; LIVER DISEASES; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ACUTE DISEASE; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CURCUMIN; DISEASE MODELS, ANIMAL; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LIVER; LIVER DISEASES; MALE; NF-KAPPA B; PEROXIDASE; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE;

EID: 84907414512     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/191624     Document Type: Article

References (22)

1. U. Haglund and D. Bergqvist, "Intestinal ischemia - the basics," Langenbeck's Archives of Surgery, vol. 384, no. 3, pp. 233-238, 1999.
2. I. H. Mallick, W. Yang, M. C. Winslet, and A. M. Seifalian, "Ischemia-reperfusion injury of the intestine and protective strategies against injury," Digestive Diseases and Sciences, vol. 49, no. 9, pp. 1359-1377, 2004.
3. L. Huang and J. Cao, "The protective effects of Shen-Fu injection on experimental acute pancreatitis in a rat model," Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 248786, 7 pages, 2014.
4. J.-H. Yao, X.-S. Zhang, S.-S. Zheng et al., "Prophylaxis with carnosol attenuates liver injury induced by intestinal ischemia/reperfusion," The World Journal of Gastroenterology, vol. 15, no. 26, pp. 3240-3245, 2009.
5. S. Bisht, G. Feldmann, S. Soni, R. Ravi, C. Karikar, and A. Maitra, "Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy," Journal of Nanobiotechnology, vol. 5, article 3, 2007.
6. Y. Zhang, C. Zhao, W. He et al., "Discovery and evaluation of asymmetrical monocarbonyl analogs of curcumin as anti-inflammatory agents," Drug Design, Development and Therapy, vol. 4, no. 8, pp. 373-382, 2014.
7. Z. C. Liu, Z. X. Yang, J. S. Zhou et al., "Curcumin regulates hepatoma cell proliferation and apoptosis through the Notch signaling pathway," International Journal of Clinical and Experimental Medicine, vol. 7, no. 3, pp. 714-718, 2014.
8. A. Onder, M. Kapan, M. Gümüş et al., "The protective effects of curcumin on intestine and remote organs against mesenteric ischemia/reperfusion injury," The Turkish Journal of Gastroenterology, vol. 23, no. 2, pp. 141-147, 2012.
9. J. S. Lane, K. E. Todd, M. P. N. Lewis et al., "Interleukin-10 reduces the systemic inflammatory response in a murine model of intestinal ischemia/reperfusion," Surgery, vol. 122, no. 2, pp. 288-294, 1997.
10. S. Sharma, S. K. Kulkarni, and K. Chopra, "Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats," Clinical and Experimental Pharmacology and Physiology, vol. 33, no. 10, pp. 940-945, 2006.
11. Y. Xu, B. Ku, L. Cui et al., "Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats," Brain Research, vol. 1162, no. 1, pp. 9-18, 2007.
12. D. E. Eckhoff, G. Bilbao, L. Frenette, J. A. Thompson, and J. L. Contreras, "17-Beta-estradiol protects the liver against warm ischemia/reperfusion injury and is associated with increased serum nitric oxide and decreased tumor necrosis factor-alpha," Surgery, vol. 132, no. 2, pp. 302-309, 2002.
13. M. Song, B. Xia, and J. Li, "Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1β, andnuclear factor κB in trinitrobenzene sulphonic acid induced colitis in rats," Postgraduate Medical Journal, vol. 82, no. 964, pp. 130-135, 2006.
14. L. Ma, G. Wang, Z. Chen et al., "Modulating the p66shc signaling pathway with protocatechuic acid protects the intestine from ischemia-reperfusion injury and alleviates secondary liver damage," The Scientific World Journal, vol. 2014, Article ID 387640, 11 pages, 2014.
15. J. Wang, L. Qiao, Y. Li, and G. Yang, "Ginsenoside Rb1 attenuates intestinal ischemia-reperfusion-induced liver injury by inhibiting NF-κB activation," Experimental and Molecular Medicine, vol. 40, no. 6, pp. 686-698, 2008.
16. T. R. S. Harward, D. L. Brooks, T. C. Flynn, and J. M. Seeger, "Multiple organ dysfunction after mesenteric artery revascularization," Journal of Vascular Surgery, vol. 18, no. 3, pp. 459-469, 1993.
17. J. Liu, G. Pan, T. Liang, and P. Huang, "HGF/c-Met signaling mediated mesenchymal stem cell-induced liver recovery in intestinal ischemia reperfusion model," International Journal of Medical Sciences, vol. 11, no. 6, pp. 626-633, 2014.
18. X. Tian, J. Yao, Y. Li et al., "Effect of nuclear factor kappa B on intercellular adhesion molecule-1 expression and neutrophil infiltration in lung injury induced by intestinal ischemia/reperfusion in rats," World Journal of Gastroenterology, vol. 12, no. 3, pp. 388-392, 2006.
19. X. Tian, J. Yao, Y. Li et al., "Protective effect of pyrrolidine dithiocarbamate on liver injury induced by intestinal ischemia-reperfusion in rats," Hepatobiliary and PancreaticDiseases International, vol. 5, no. 1, pp. 90-95, 2006.
20. J. H. Yao, Y. H. Li, Z. Z. Wang et al., "Proteasome inhibitor lactacyst in ablates liver injury induced by intestinal ischemia/reperfusion," Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 11, pp. 1102-1108, 2007.
21. H. Jing, G. Shen, G. Wang et al., "MG132 alleviates liver injury induced by intestinal ischemia/reperfusion in rats: involvement of the AhR and NFκB pathways," Journal of Surgical Research, vol. 176, no. 1, pp. 63-73, 2012.
22. Z.-Z. Wang, W.-J. Zhao, X.-S. Zhang et al., "Protection of Veratrum nigrum L. var. ussuriense Nakai alkaloids against ischema-reperfusion injury of the rat liver," The World Journal of Gastroenterology, vol. 13, no. 4, pp. 564-571, 2007.